GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

$24.58
-0.02 (-0.08%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +96.2% upside
Low Target $34.28
Average Target $48.23
High Target $66.93
Current Price $24.58
Current
$24.58
Target
$48.23
$34.28 $48.23 avg $66.93
Scenario Analysis
Bear Case
$34.28
39.5%
Low target
Base Case
$48.23
+96.2%
Avg target
Bull Case
$66.93
+172.3%
High target
Risk/Reward
4.4x
Highly favorable
Price in Context
52-Week High
$25.94
-5.2% from high
52-Week Low
$11.32
+117.1% from low
Target vs 52W High
$48.23
+85.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%